| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.031 | 0.9 |